Pharmaceutical Analytical Testing Market, By Service Type (Bioanalytical Testing, Method Development and Validation, Stability Testing, Drug Substances Testing, and Others), By End User (Biopharmaceutical Companies, Contract Research Organizations, Medical Device Companies, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Feb 2025

Code : CMI5383

Pages :173

Formats :

Excel and PDF

Industry : Medical Devices

Pharmaceutical Analytical Testing Market Size and Trends

The pharmaceutical analytical testing market is estimated to be valued at USD 9.16 billion in 2025 and is expected to reach USD 16.65 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.9% from 2025 to 2032.

Pharmaceutical Analytical Testing Market Key Factors

To learn more about this report, Request sample copy

The pharmaceutical analytical testing market is driven by the increased R&D expenditure in pharmaceutical and biotechnology companies. The stringent regulatory guidelines for drug development and safety have increased the demand for analytical testing. Moreover, the growth of generics and biosimilars has significantly contributed to the market expansion. However, the high cost of analytical instruments and lack of skilled professionals are the major factors limiting the market growth.

Increasing R&D investment in drug development

Increased research and development activities, along with collaborations and strategic agreements, are expected to fuel the market growth. For instance, in November 2021, Alcami Corporation, Inc., a contract development and manufacturing organization, entered into a master laboratory services agreement with Novavax, a biotechnology company. Through this agreement, Novavax secured full-time equivalent (FTE) resources to provide analytical testing support for its recombinant nanoparticle protein-based COVID-19 vaccine candidate with Matrix-M adjuvant. These developments are projected to drive market expansion.